Press Releases
Filters
July 29, 2026
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
June 29, 2026
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
May 18, 2026
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
May 7, 2026
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
Displaying 1 - 10 of 198
